Invivox
|

Investors

Educapital

Educapital

Created in 2017 by Marie-Christine Levet and Litzie Maarek, Educapital is the first impact investment fund dedicated to the future of education and work. Educapital invests from late seed to series B in companies that innovate in the education and workplace sector, from early childhood to contidocnuing education. Educapital's ambition is to help European Edtech champions emerge by providing financial support and expertise. To date, Educapital has invested in 22 European Edtech companies, including Lunii, 360Learning, LiveMentor, Labster, Preply, Simundia among others.

MACSF

MACSF

MACSF (Mutuelle d'assurance du corps de santé français) is the leading insurer of healthcare professionals and has been serving all healthcare professionals in France for over a century. It employs 1,600 people and has a turnover of around 2 billion euros. Faithful to its vocation as a professional mutual insurance company, MACSF insures the risks of the private and professional life of more than one million members and clients.

Bpifrance

Bpifrance

The Fonds Patient Autonome, launched by BPIFrance, financially supports startups working on medical technology. Provided with 50 million euros, these investments aim to identify and develop the most promising French startups in the medical technology industry.

ISAI

ISAI

Investment funds for internet entrepreneurs. The creation of the ISAI originated in the shared desire of certain entrepreneurs coming from the IT, Communication and Web industries to structure and professionalize their direct investment into young, innovative companies.

Educapital

Ethicapital partners

An independent corporation supporting companies through its investment group. The funds come exclusively from the founder Patrice Mayolle, investing in many European business sectors while becoming a major partner in the development and handover of Small and Medium Sized Enterprises.

Fine Day Ventures

Fine Day Ventures

Fine Day Ventures is an early stage venture capital firm investing in technology, specifically financial technology, medical technology and aerospace technology, artificial intelligence and energy (alternative and traditional). Founder Claude Wasserstein has invested in a number of startups, including Blade, Hyperloop, Flare (board member), Maven, Ambulnz, BitPesa, and Tentrr.

Board members

Julien Delpech

Julien Delpech

Co-founder and CEO of Invivox, Mission: "Creation & Dissemination of content to health professionals in the event of a new health crisis" at the French Ministry of Solidarity and Health

Patxi Ospital

Patxi Ospital

Co-founder & Managing Director at Invivox

Marie Geneste

Marie Geneste

Invivox Board member, Venture Capital investor

Thierry Houselstein

Thierry Houselstein

Invivox board member, Medical Director at Macsf

Maud Kelly Crapeau

Maud Kelly Crapeau

Invivox board member, Portfolio Management

So-Yeon Koo

So-Yeon Koo

Invivox board member, Venture Capital Investor at Bpifrance

Jean-Patrice Anciaux

Jean-Patrice Anciaux

Invivox board member, Early stage VC / Partner @ISAI

Chahra Louafi

Chahra Louafi

Chahra Louafi is Director of Senior Investments and Manager of Funds in Innovative Biotherapy and Rare Disease at BPIFrance (formerly CDC Enterprises), currently in charge of 10 societies. Since January 2018, she has managed the « Autonomous Patient » Funds that she herself established. Before joining CDC Enterprises in 2001 she was in charge of project management and business creation in a private business incubator specialised in the field of biotechnology.